During the past decade, Auckland City Hospital, Cancer and Blood Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auckland City Hospital, Cancer and Blood Research" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator, "Fondazione Michelangelo" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Auckland City Hospital, Cancer and Blood Research" are "Breast Cancer" (2 trials), "Non-small Cell Lung Cancer (NSCLC)" (2 trials), "Adenocarcinoma" (1 trials), "Bronchial Diseases" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Auckland City Hospital, Cancer and Blood Research" in a lesser frequency.

Most popular intervention types in "Auckland City Hospital, Cancer and Blood Research" are "Drug" (19 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (11 trials), "Placebo" (4 trials), "Paclitaxel" (3 trials), "Tiragolumab" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Auckland City Hospital, Cancer and Blood Research" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Auckland City Hospital, Cancer and Blood Research". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Auckland City Hospital, Cancer and Blood Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Auckland City Hospital, Cancer and Blood Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".